L3VLUP
ProSign in

CRL in the 13F filings

Charles Riv Labs Intl Inc · CUSIP 159864107

Sector · Health care services and researchTheme · Healthcare: biopharma and medtech· L3VLUP-defined
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Quarter end
30 Sep 2024
the date the book describes
Filed
10 Feb 2025
latest of these filings; the earliest 5 Nov 2024
Managers listing it
9
at least, of 95 tracked, among listed positions
Comparable managers
94
filed both Q2 2024 and Q3 2024; 6 listed it in both
Shares listed
4,559,087
combined, among listed positions
Reported value
$898m
combined, at the quarter end

Among the 94 comparable managers: 6 buyers (opened or added shares) and 3 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.

Managers listing CRL in Q3 2024

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q2 2024, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

9 of 9 holders

ActionFiling
Wellington Management Group LLP3,740,768$737m0.13%Addedn.a.14 Nov 2024 (the filing on sec.gov)
Neuberger Berman Group LLC312,962$62munder 0.1%Added+5,50514 Nov 2024 (the filing on sec.gov)
Marshall Wace LLP309,059$61m0.07%Trimmed-516,84614 Nov 2024 (the filing on sec.gov)
Voloridge Investment Management LLC75,656$15m0.05%Addedn.a.14 Nov 2024 (the filing on sec.gov)
Baillie Gifford & Co68,585$14munder 0.1%Added+1,0485 Nov 2024 (the filing on sec.gov)
Winton Group Ltd29,121$5.7m0.40%Added+27,02012 Nov 2024 (the filing on sec.gov)
PDT Partners LLC9,263$1.8m0.16%Trimmed-3,50014 Nov 2024 (the filing on sec.gov)
Quantbot Technologies LP8,169$1.6m0.06%Newnew13 Nov 2024 (the filing on sec.gov)
Polen Capital Management LLC5,504$1.1munder 0.1%Trimmed-21110 Feb 2025 (the filing on sec.gov)

Largest increases and reductions, by shares

Q2 2024 to Q3 2024, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (1)

Exited (0)

No exit shown by a manager’s own filing.

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
9 in Q3 2024 to 12 in Q2 2026

Tracked managers listing it, at least.

051015202014201620182020202220242026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
CRL by quarter
QuarterHoldersReported valueBuyersSellers
Q2 20136$199mn.a.n.a.
Q3 20139$335mn.a.n.a.
Q4 20139$379mn.a.n.a.
Q1 201411$503mn.a.n.a.
Q2 20147$377mn.a.n.a.
Q3 201410$529mn.a.n.a.
Q4 20147$417mn.a.n.a.
Q1 201513$625mn.a.n.a.
Q2 201510$302mn.a.n.a.
Q3 20157$258mn.a.n.a.
Q4 201510$396mn.a.n.a.
Q1 201613$460mn.a.n.a.
Q2 201612$479mn.a.n.a.
Q3 201610$532mn.a.n.a.
Q4 201612$549mn.a.n.a.
Q1 201713$559mn.a.n.a.
Q2 201716$953mn.a.n.a.
Q3 201714$948mn.a.n.a.
Q4 201711$959mn.a.n.a.
Q1 201811$867mn.a.n.a.
Q2 20189$590mn.a.n.a.
Q3 201811$725mn.a.n.a.
Q4 201814$655mn.a.n.a.
Q1 201911$910mn.a.n.a.
Q2 201912$839mn.a.n.a.
Q3 201910$662mn.a.n.a.
Q4 201910$783mn.a.n.a.
Q1 202010$778mn.a.n.a.
Q2 202012$1.0bnn.a.n.a.
Q3 202012$1.4bnn.a.n.a.
Q4 202015$1.5bnn.a.n.a.
Q1 202114$2.1bnn.a.n.a.
Q2 202114$2.5bnn.a.n.a.
Q3 202111$2.8bnn.a.n.a.
Q4 202115$2.7bnn.a.n.a.
Q1 202215$1.8bnn.a.n.a.
Q2 202217$1.1bnn.a.n.a.
Q3 202216$1.1bnn.a.n.a.
Q4 202211$1.1bnn.a.n.a.
Q1 20239$864mn.a.n.a.
Q2 20239$755mn.a.n.a.
Q3 202310$475mn.a.n.a.
Q4 20239$536m46
Q1 20249$664m56
Q2 20247$385m42
Q3 20249$898m63
Q4 202410$1.0bn83
Q1 202512$1.0bn94
Q2 202515$1.3bn126
Q3 202511$1.2bn82
Q4 202516$2.1bn1919
Q1 202614$2.7bn1719
Q2 202612$3.7bn1119

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

CRL and LLY →CRL and JNJ →CRL and VRTX →Choose a stock to compare with CRL →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own CRL, latest filings →Back to the 13F Explorer →